tiprankstipranks
Trending News
More News >
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
US Market

Janux Therapeutics Inc (JANX) Income Statement

Compare
598 Followers

Janux Therapeutics Inc Income Statement

Last quarter (Q3 2025), Janux Therapeutics Inc's total revenue was $10.00M, an increase of 2177.90% from the same quarter last year. In Q3, Janux Therapeutics Inc's net income was $-24.31M. See Janux Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.59M$ 8.08M$ 8.61M$ 3.64M$ 0.00
Gross Profit
$ 8.53M$ 6.13M$ 7.77M$ 3.64M$ -13.00K
Operating Expenses
$ 107.38M$ 79.11M$ 74.86M$ 36.57M$ 4.83M
Depreciation and Amortization
$ 2.06M$ 1.96M$ 841.00K$ 113.00K$ 13.00K
EBITDA
$ -96.79M$ -71.02M$ -66.25M$ -32.82M$ -6.57M
Operating Income
$ -98.85M$ -72.98M$ -67.09M$ -32.93M$ -4.84M
Other Income/Expenses
$ 29.85M$ 14.69M$ 4.03M$ 257.00K$ -1.94M
Pretax Income
$ -68.99M$ -58.29M$ -63.06M$ -32.67M$ -6.78M
Net Income
$ -68.99M$ -58.29M$ -63.06M$ -32.67M$ -6.78M
Per Share Metrics
Basic EPS
$ -1.28$ -1.32$ -1.52$ -0.79$ -0.16
Diluted EPS
$ -1.28$ -1.32$ -1.52$ -0.79$ -0.16
Weighted Average Shares Outstanding
53.75M 44.02M 41.47M 41.24M 41.61M
Weighted Average Shares Outstanding (Diluted)
53.75M 44.02M 41.47M 41.24M 41.61M
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History